Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt)

Human Genetics

Volumn 134, Issue 1, 2015, Pages 111-121

  Sikora, Jacquelyn L ^a   Logue, Mark W ^a   Chan, Gloria G ^a   Spencer, Brian H ^a   Prokaeva, Tatiana B ^a   Baldwin, Clinton T ^a   Seldin, David C ^a   Connors, Lawreen H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PREALBUMIN;

ADULT; AGED; ALLELE; AMYLOIDOSIS; ARTICLE; BINDING AFFINITY; BLADDER BIOPSY; CARDIOMYOPATHY; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; DNA SEQUENCE; EXON; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART FAILURE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BIOPSY; SURVIVAL; VERY ELDERLY; WILD TYPE TRANSTHYRETIN AMYLOIDOSIS; CASE CONTROL STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; FOLLOW UP; GENETICS; MIDDLE AGED; PROGNOSIS;

AGED; AGED, 80 AND OVER; AMYLOID NEUROPATHIES, FAMILIAL; CASE-CONTROL STUDIES; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREALBUMIN; PROGNOSIS;

EID: 84922005381     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1499-0     Document Type: Article

References (44)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
2. Buxbaum J, Koziol J, Connors LH (2008) Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity. Amyloid 15:255–261
3. Buxbaum J, Anan I, Suhr O (2010) Serum transthyretin levels in Swedish TTR V30M carriers. Amyloid 17:83–85
4. Cartharius K, Frech K, Grote K et al (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942
5. Connors LH, Lim A, Prokaeva T et al (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10:160–184
6. Connors LH, Doros G, Sam F et al (2011) Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy. Amyloid 18(Suppl 1):157–159
7. Cornwell GG 3rd, Murdoch WL, Kyle RA et al (1983) Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 75:618–623
8. Costa RH, Grayson DR (1991) Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res 19:4139–4145
9. Costa RH, Lai E, Darnell JE Jr (1986) Transcriptional control of the mouse prealbumin (transthyretin) gene: both promoter sequences and a distinct enhancer are cell specific. Mol Cell Biol 6:4697–4708
10. Costa RH, Grayson DR, Xanthopoulos KG, Darnell JE Jr (1988a) A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha 1-antitrypsin, albumin, and simian virus 40 genes. Proc Natl Acad Sci 85:3840–3844
11. Costa RH, Lai E, Grayson DR, Darnell JE Jr (1988b) The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites. Mol Cell Biol 8:81–90
12. Costa RH, Grayson DR, Darnell JE Jr (1989) Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol Cell Biol 9:1415–1425
13. Costa RH, Van Dyke TA, Yan C et al (1990) Similarities in transthyretin gene expression and differences in transcription factors: liver and yolk sac compared to choroid plexus. Proc Natl Acad Sci 87:6589–6593
14. Courtois G, Baumhueter S, Crabtree GR (1988) Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci 85:7937–7941
15. Falk RH, Skinner M (2000) The systemic amyloidoses: an overview. Adv Intern Med 45:107–137
16. Fitch NJ, Akbari MT, Ramsden DB (1991) An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 129:309–313
17. Grayson DR, Costa RH, Xanthopoulos KG, Darnell JE (1988) One factor recognizes the liver-specific enhancers in alpha 1-antitrypsin and transthyretin genes. Science 239:786–788
18. Jacobson DR, Alves IL, Saraiva MJ et al (1995) Transthyretin Ser 6 gene frequency in individuals without amyloidosis. Hum Genet 95:308–312
19. Kisilevsky R (1991) Amyloid and amyloidoses: differences, common themes, and practical considerations. Mod Pathol 4:514–518
20. Macintyre G, Bailey J, Haviv I, Kowalczyk A (2010) is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 26:i524–i530
21. Martinho A, Santos CR, Goncalves I (2013) A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERalpha and/or ERbeta transactivation. Gene 527:469–476
22. Mathelier A, Zhao X, Zhang AW et al (2014) JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 42:D142–D147
23. Merlini G, Westermark P (2004) The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 255:159–178
24. Meyer LR, Zweig AS, Hinrichs AS et al (2013) The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41:D64–D69
25. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH (2005) Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 165:1425–1429
26. Norgren N, Hellman U, Ericzon BG et al (2012) Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. PLoS One 7:e49981
27. Olsson M, Norgren N, Obayashi K et al (2010) A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers. BMC Med Genet 11:130
28. Polimanti R, Di Girolamo M, Manfellotto D, Fuciarelli M (2013) Functional variation of the transthyretin gene among human populations and its correlation with amyloidosis phenotypes. Amyloid 20:256–262
29. Pruim RJ, Welch RP, Sanna S et al (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26:2336–2337
30. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
31. Qian X, Samadani U, Porcella A, Costa RH (1995) Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription. Mol Cell Biol 15:1364–1376
32. Rostom AA, Sunde M, Richardson SJ et al (1998) Dissection of multi-protein complexes using mass spectrometry: subunit interactions in transthyretin and retinol-binding protein complexes. Proteins (Suppl 2):3–11
33. Sakaki Y, Yoshioka K, Tanahashi H et al (1989) Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Mol Biol Med 6:161–168
34. Samadani U, Qian X, Costa RH (1996) Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform. Gene Expr 6:23–33
35. Saraiva MJ (2001) Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 17:493–503
36. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y (1985) Structure of the chromosomal gene for human serum prealbumin. Gene 37:191–197
37. Sipe JD, Benson MD, Buxbaum JN et al (2010) Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17:101–104
38. Soares ML, Coelho T, Sousa A et al (2004) Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Eur J Hum Genet 12:225–237
39. Tanskanen M, Peuralinna T, Polvikoski T et al (2008) Senile systemic amyloidosis affects 25 % of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 40:232–239
40. Tsuzuki T, Mita S, Maeda S et al (1985) Structure of the human prealbumin gene. J Biol Chem 260:12224–12227
41. US Census Bureau (2012) USC: 2010 Census Special Reports, Centenarians: 2010, C2010SR-03. Washington, DC
42. Westermark P, Bergstrom J, Solomon A et al (2003) Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 10(Suppl 1):48–54
43. Wingender E (2008) The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform 9:326–332
44. Zaros C, Genin E, Hellman U et al (2008) On the origin of the transthyretin Val30Met familial amyloid polyneuropathy. Ann Hum Genet 72:478–484